tykhr
sign in
free sign up
ArriVent BioPharma, Inc. Common Stock
Biotechnology
Healthcare
AVBP
33.58 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
15.91
52 week high
35.63
high
17.92
52 week low
16.30
low
15.55
growth
-9.53 %
previous Close
16.30
P/E ratio
market cap
879 M
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
-20.56 M
5.99 %
eps
0.00 %
6.15 %
eps surprise
42.84 %
net profit margin
-2056400000.00 %
0.00 %
operating incoming
-24.23 M
5.70 %
net change in cash
-15.81 M
15.54 %
cash on hand
150 M
-49.65 %
cost of revenue
0.00 %
top